Melanoma cells transfected to express CD83 induce antitumor immunity that can be increased by also engaging CD137
Shilin Yang(Second Military Medical University), Karl Erik Hellström(Bristol-Myers Squibb (Germany)), Ze’ev A. Ronai(Cedars-Sinai Medical Center), John Raycraft(Icahn School of Medicine at Mount Sinai), Yi Yang(Soochow University), Hongtao Zhang(Chinese Academy of Sciences), Yajun Guo(Eastern Hepatobiliary Surgery Hospital), Ingegerd Hellström(Pacific Northwest Diabetes Research Institute), Sandra Kanan(University of Washington Medical Center)
Cited by 44
Related Papers
Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia
|New England Journal of Medicine|2015|937
National Survey of Drug-Resistant Tuberculosis in China
|New England Journal of Medicine|2012|649
ErbB receptors: from oncogenes to targeted cancer therapies
|Journal of Clinical Investigation|2007|578
Advances in clinical immunotherapy for gastric cancer
|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2021|435
Emerging roles of ATF2 and the dynamic AP1 network in cancer
|Nature reviews. Cancer|2009|366